Instituto de Investigación, Innovación y Tecnología Educativas (UNIR iTED)
Facultad
University of Copenhagen
Copenhague, DinamarcaPublications in collaboration with researchers from University of Copenhagen (26)
2017
-
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: A multinational, multicohort European study
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 10, pp. 2869-2878
2016
-
Infection-related and -unrelated malignancies, HIV and the aging population
HIV Medicine, Vol. 17, Núm. 8, pp. 590-600
2015
-
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study
HIV Medicine, Vol. 16, Núm. 9, pp. 533-543
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
2014
-
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe
Infection, Vol. 42, Núm. 4, pp. 757-762
-
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study
BMC Nephrology, Vol. 15, Núm. 1
-
High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance
HIV Medicine, Vol. 15, Núm. 10, pp. 615-620
-
Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe
PLoS ONE, Vol. 9, Núm. 1
2013
-
Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
Journal of Hepatology, Vol. 59, Núm. 2, pp. 213-220
-
Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients
PLoS ONE, Vol. 8, Núm. 5
-
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study
BMC Infectious Diseases, Vol. 13, Núm. 1
-
Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy
HIV Medicine, Vol. 14, Núm. 6, pp. 370-378
-
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA
HIV Medicine, Vol. 14, Núm. 10, pp. 614-623
2012
2011
-
A376s in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy
Journal of Infectious Diseases, Vol. 204, Núm. 5, pp. 741-752
-
European recommendations for the clinical use of HIV drug resistance testing: 2011 update
AIDS Reviews, Vol. 13, Núm. 2, pp. 77-108
-
Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART study
Antiviral Therapy, Vol. 16, Núm. 5, pp. 667-675
2010
-
Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption
AIDS, Vol. 24, Núm. 6, pp. 857-865
-
Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe
Journal of Antimicrobial Chemotherapy, Vol. 65, Núm. 3, pp. 548-555
2009
-
Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression
Journal of Acquired Immune Deficiency Syndromes, Vol. 50, Núm. 5, pp. 457-463